182 related articles for article (PubMed ID: 27725123)
1. Treatment of IgG4-related pachymeningitis in a patient with steroid intolerance: The role of early use of rituximab.
Gospodarev V; Câmara J; Chakravarthy V; Perry A; Wood M; Dietz R; Wang J; De Los Reyes K; Raghavan R
J Neuroimmunol; 2016 Oct; 299():62-65. PubMed ID: 27725123
[TBL] [Abstract][Full Text] [Related]
2. Steroid-resistant relapsing IgG4-related pachymeningitis treated with methotrexate.
Hyun JW; Kim SH; Yoo H; Hong EK; Huh SY; Kim HJ
JAMA Neurol; 2014 Feb; 71(2):222-5. PubMed ID: 24322883
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin-G4-related hypertrophic pachymeningitis with antineutrophil cytoplasmatic antibodies effectively treated with rituximab.
Popkirov S; Kowalski T; Schlegel U; Skodda S
J Clin Neurosci; 2015 Jun; 22(6):1038-40. PubMed ID: 25861887
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal rituximab in immunoglobulin G4-hypertrophic pachymeningitis.
Soares C; Martins DF; Pestana-Silva R; Honavar M; Faria O; Abreu P; Costa A
J Neuroimmunol; 2019 Sep; 334():576997. PubMed ID: 31254930
[TBL] [Abstract][Full Text] [Related]
5. Rituximab for corticosteroid-resistant relapsing IgG4-related intracranial pachymeningitis: report of two cases.
Mageau A; Shor N; Fisselier M; Aboab J; Lecler A; Rebours C; Adle-Biassette H; Gout O; Deschamps R
Pract Neurol; 2018 Apr; 18(2):159-161. PubMed ID: 29208730
[TBL] [Abstract][Full Text] [Related]
6. Metachronous Involvement, Diagnostic Imprecision of Serum Immunoglobulin G4 Levels, and Discordance Between Clinical and Radiological Findings in Immunoglobulin G4-Related Pachymeningitis: A Longitudinal Case Report.
Waheed W; Skidd PM; Borden NM; Gibson PC; Babi MA; Tandan R
J Clin Rheumatol; 2017 Jun; 23(4):215-221. PubMed ID: 28248797
[TBL] [Abstract][Full Text] [Related]
7. Probable IgG4-related pachymeningitis: a case with transverse sinus obliteration.
Tanboon J; Felicella MM; Bilbao J; Mainprize T; Perry A
Clin Neuropathol; 2013; 32(4):291-7. PubMed ID: 23320997
[TBL] [Abstract][Full Text] [Related]
8. IgG4-related pachymeningitis-Long term follow up and outcome of six patients.
Yardimci GK; Arslan D; Babaoğlu B; Bolek EC; Kilic L; Saglam A; Tuncer A; Söylemezoğlu F; Gocmen R; Oguz KK; Tan E; Karadag O
Int J Rheum Dis; 2023 Sep; 26(9):1853-1860. PubMed ID: 37403944
[TBL] [Abstract][Full Text] [Related]
9. IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment.
Lu LX; Della-Torre E; Stone JH; Clark SW
JAMA Neurol; 2014 Jun; 71(6):785-93. PubMed ID: 24733677
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal rituximab for IgG
Della-Torre E; Campochiaro C; Cassione EB; Albano L; Gerevini S; Bianchi-Marzoli S; Bozzolo E; Passerini G; Lanzillotta M; Terreni M; Callea M; Trimarchi M; Mortini P; Tresoldi M; Acerno S; Dagna L
J Neurol Neurosurg Psychiatry; 2018 Apr; 89(4):441-444. PubMed ID: 28819060
[No Abstract] [Full Text] [Related]
11. Investigation of IgG4-positive cell infiltration in biopsy specimens from cases of hypertrophic pachymeningitis.
Utsuki S; Kijima C; Fujii K; Miyakawa S; Iizuka T; Hara A
Clin Neuropathol; 2013; 32(2):84-90. PubMed ID: 23211431
[TBL] [Abstract][Full Text] [Related]
12. [A Case of IgG4-related Hypertrophic Pachymeningitis].
Hayashi K; Somagawa C; Hayashi Y; Iwanaga M
No Shinkei Geka; 2018 Dec; 46(12):1103-1109. PubMed ID: 30572308
[TBL] [Abstract][Full Text] [Related]
13. Clinical presentation, treatment and outcome of IgG4-related pachymeningitis: From a national case registry and literature review.
Melenotte C; Seguier J; Ebbo M; Kaphan E; Bernit E; Saillier L; Audoin B; Feyeux D; Daniel L; Roche PH; Graillon T; Dufour H; Boutière C; Girard N; Closs-Prophette F; Guillaud C; Tieulié N; Regent A; Harlé JR; Hamidou M; Mekinian A; Grados A; Schleinitz N
Semin Arthritis Rheum; 2019 Dec; 49(3):430-437. PubMed ID: 31155444
[TBL] [Abstract][Full Text] [Related]
14. [Rituximab therapy for relapsing IgG4-autoimmune pancreatitis and cholangitis - a case report].
Mueller J; Schmidt A; Herrmann G; Caca K
Z Gastroenterol; 2015 Jan; 53(1):40-2. PubMed ID: 25594706
[TBL] [Abstract][Full Text] [Related]
15. Rituximab Maintenance Therapy Reduces Rate of Relapse of Pancreaticobiliary Immunoglobulin G4-related Disease.
Majumder S; Mohapatra S; Lennon RJ; Piovezani Ramos G; Postier N; Gleeson FC; Levy MJ; Pearson RK; Petersen BT; Vege SS; Chari ST; Topazian MD; Witzig TE
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1947-1953. PubMed ID: 29526692
[TBL] [Abstract][Full Text] [Related]
16. Leptomeningeal form of Immunoglobulin G4-related hypertrophic meningitis with perivascular spread: a case report and review of the literature.
Boban J; Ardalı S; Thurnher MM
Neuroradiology; 2018 Jul; 60(7):769-773. PubMed ID: 29736618
[TBL] [Abstract][Full Text] [Related]
17. IgG4-related hypertrophic pachymeningitis of the spine with MPO-ANCA seropositivity.
Maher M; Zanazzi G; Faust P; Nickerson K; T Wong T
Clin Imaging; 2017; 46():108-112. PubMed ID: 28768224
[TBL] [Abstract][Full Text] [Related]
18. Refractory IgG4-related disease complicated with organising pneumonia and hypertrophic pachymeningitis.
Abe F; Michishita Y; Saito M; Nara M; Wakui H; Takahashi N
Mod Rheumatol Case Rep; 2022 Jun; 6(2):278-281. PubMed ID: 35355069
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of IgG4 Indices in IgG4-related hypertrophic pachymeningitis.
Della-Torre E; Galli L; Franciotta D; Bozzolo EP; Briani C; Furlan R; Roveri L; Sessa M; Passerini G; Sabbadini MG
J Neuroimmunol; 2014 Jan; 266(1-2):82-6. PubMed ID: 24289956
[TBL] [Abstract][Full Text] [Related]
20. Predictors of disease relapse in IgG4-related disease following rituximab.
Wallace ZS; Mattoo H; Mahajan VS; Kulikova M; Lu L; Deshpande V; Choi HK; Pillai S; Stone JH
Rheumatology (Oxford); 2016 Jun; 55(6):1000-8. PubMed ID: 26888853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
